Wollenberg, Andreas http://orcid.org/0000-0003-0177-8722
Gooderham, Melinda http://orcid.org/0000-0001-8926-0113
Katoh, Norito http://orcid.org/0000-0002-3498-2482
Aoki, Valeria http://orcid.org/0000-0003-4256-4413
Pink, Andrew E. http://orcid.org/0000-0001-5151-5539
Binamer, Yousef http://orcid.org/0000-0003-0948-7102
Silverberg, Jonathan I. http://orcid.org/0000-0003-3686-7805
Funding for this research was provided by:
Universitätsklinikum Augsburg
Article History
Received: 9 February 2024
Revised: 29 April 2024
Accepted: 2 May 2024
First Online: 8 June 2024
Declarations
:
: AW is a consultant for AbbVie, Aileens, Almirall, Beiersdorf, Eli Lilly, Galderma, GlaxoSmithKline, Janssen, LEO Pharma, L’Oreal, MedImmune, MSD, Novartis, Pfizer, Pierre Fabre, Regeneron Pharmaceuticals, Inc., and Sanofi; an investigator for AbbVie, Almirall, Anacor Pharmaceuticals, Eli Lilly, Galapagos, Galderma, Glenmark, LEO Pharma, MedImmune, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Sanofi, and UCB; and received research grants from Pierre Fabre. MG is an investigator, speaker, and/or advisor for AbbVie, Akros, Amgen, AnaptysBio, Arcutis, Aristea, Aslan, Bausch Health, BMS, Boehringer Ingelheim, Celgene, Dermavant, Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Kirin, LEO Pharma, MedImmune, Meiji, Merck, Moonlake, Nimbus, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Roche, Sanofi-Genzyme, Sun Pharma, UCB, and Ventyx. NK received honoraria as a speaker/consultant for AbbVie, Celgene Japan, Eli Lilly Japan, Jansen Pharma, Kyowa Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe Pharma, Sanofi, Taiho Pharmaceutical, and Torii Pharmaceutical; and received grants as an investigator from A2 Healthcare, AbbVie, Boehringer Ingelheim Japan, Eisai, Eli Lilly Japan, Jansen Pharma, Kyowa Kirin, LEO Pharma, Maruho, Sun Pharma, Taiho Pharmaceutical, and Torii Pharmaceutical. VA is an investigator for Sanofi and Eli Lilly (clinical trials); and is a consultant and/or speaker for AbbVie and Pfizer. AEP is an advisory board member of, investigator for, recipient of grants from, or recipient of educational support from AbbVie, Almirall, Amgen, BMS, Boehringer Ingelheim, Celgene, Eli Lilly, Galderma, Janssen, LEO Pharma, Novartis, Pfizer, Sanofi-Genzyme, and UCB. YB received speaker honoraria for, honoraria serving as a consultant for, and travel support from AbbVie, Eli Lilly, Janssen, Kyowa Kirin, NewBridge, Novartis, and Sanofi; and received research grants from Novartis and Sanofi. JIS is an investigator for AbbVie, BMS, Eli Lilly, GlaxoSmithKline, Incyte, Kiniksa Pharmaceuticals, LEO Pharma, Realm Therapeutics, and Regeneron Pharmaceuticals, Inc.; a consultant for AbbVie, Alamar, Amgen, AObiome, Arcutis, Arena, Asana, Aslan, BioMX, Biosion, Bodewell, Boehringer Ingelheim, Cara, Castle Biosciences, Celgene, Connect Biopharma, Dermavant, Dermira, Dermtech, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Kiniksa, LEO Pharma, Menlo, Novartis, Optum, Pfizer, RAPT, Regeneron Pharmaceuticals, Inc., Sanofi-Genzyme, Shaperon, and Union; and a speaker for AbbVie, Eli Lilly, LEO Pharma, Pfizer, Regeneron Pharmaceuticals, Inc., and Sanofi-Genzyme.
: All subjects gave their informed consent for inclusion before they participated in the study. This market research was exempt from ethics approvals.